Align Technology | ALGN - Capitale Di Prestito

Prezzo Delle Azioni
176.18
Cambio Giornaliero
-2.22 -1.24%
Mensile
2.77%
Annuale
-0.32%
Q2 Previsione
185.55




Capitale Di Prestito Cambiamento Data
3M USD 10.91B 26M 2026-03
Align Technology USD 0 0 2024-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bruker USD 1.85B 131.7M 2025-12
Cardinal Health USD 8.35B 633M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cooper Companies USD 1.88B 578.5M 2025-12
CVS Health USD 60.5B 6M 2025-12
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.02B 2M 2025-12
Dexcom USD 1.24B 53.6M 2025-12
Henry Schein USD 2.31B 157M 2025-12
Idexx Laboratories USD 374.84M 17K 2025-12
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Masimo USD 518M 41.1M 2025-12
McKesson USD 5.43B 586M 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Revvity USD 2.63B 543K 2025-12
Solventum Corp USD 5.04B 102M 2025-12
Stryker USD 14.86B 14M 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Waters USD 1.41B 460.24M 2025-12
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03
Zoetis USD 9.04B 1.97B 2025-12